SquamousCellCarcinomaofSkin near Summit, NJ

Care Philosophy: I am dedicated to providing personalized, quality cancer care to my patients in partnership with Robert Wood Johnson University Hospital Somerset, which has been nationally recognized for patient safety, clinical outcomes and nursing excellence. Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with a physician office that they are still a participating provider.

Care Philosophy: I am dedicated to providing personalized quality cancer care to my patients in partnership with Robert Wood Johnson University Hospital Somerset which has been nationally recognized for patient safety clinical outcomes and nursing excellence Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with a physician office that they are still a participating provider.

Biography: Dr. Louise Ligresti, MD is an Oncology Specialist who practices in Livingston, NJ. She is 60 years old and has been practicing for 34 years. Dr. Louise Ligresti, MD is affiliated with Cooperman Barnabas Medical Center and Robert Wood Johnson University Hospital.

Care Philosophy: I chose this career to take care of patients with serious illnesses and provide all the resources available to help with this difficult journey. The most enjoyable aspect is the relationship that I develop with you and your family, and it's an hono Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with a physician office that they are still a participating provider.

Care Philosophy: Dr. Shah and the Gastrointestinal Oncology group are committed to providing excellent and personalized care for you and your loved ones. We would welcome the opportunity to take part in your care, whether it involves primary management or for consultation in conjunction with your treating physicians. Ensuring you are receiving the best and most comprehensive treatment for your malignancy is our aim. Please feel free to contact us for an appointment, or have your physician contact us to discuss your care.

Care Philosophy: After developing an interest in fighting cancer in medical school, I was fortunate to work with and learn from leadersin the field of genitourinary oncology during internship, residency, and fellowship training. I feel fortunate to have joined the faculty at Weill Cornell to work with renowned mentors and colleagues in both medical oncology and urology. Together I am confident we will make progress towards increasing the cure rate and decreasing suffering from these diseases.

Care Philosophy: Our Lymphoma group has been at the forefront in the development of targeted therapies for CLL and other lymphoid malignancies. We strive to bring effective therapeutics to patients, years before they are widely available. I am fortunate to practice oncology in such an exciting era with rapidly improving diagnostic and therapeutic options. I seek to incorporate the latest breakthroughs and technology in providing care to my patients. Comprehensive in my approach, I am driven to understand the underlying biology of the disease, individualizing each patient's treatment plan. I offer patients a unique experience, with compassion for the patient and their family. With a large portfolio of clinical trials, our group offers ample opportunities for patients to participate in clinical research. Our hospital system is award winning and provides access to world-class consultants for all medical conditions. It will be a privilege to care for you or your family member.

Care Philosophy: My first priority is the patient sitting in front of me. I have a longstanding interest in cancer care and have been specifically focused on lymphoma since my father was diagnosed with Hodgkin lymphoma when I was a medical student. At Weill Cornell, our experienced team of lymphoma specialists works together to determine the most appropriate therapy for each individual patient. Our group has played a key role in the development of many new therapies approved for lymphoma in recent years. As a result, our patients have early access to new and promising lymphoma treatments. We are fortunate to have a strong team of physician assistants, nurses, medical technicians, pharmacists, and administrative staff. This environment enables me to provide my patients with the best possible level of care.

Biography: Pinkal Desai MD, MPH is an Assistant Professor of Medicine at Weill Cornell Medical College and Assistant Attending Physician at the New York-Presbyterian Hospital.After obtaining her MBBS at Byramjeejeebhoy Medical College in India in 2005, Dr. Desai obtained an MPH at the University of Alabama at Birmingham School of Public Health. Following her residency at Wayne State University, Detroit Medical Center, she underwent fellowship training in Hematology-Medical Oncology at Providence Hospital Medical Center, serving as Chief Fellow from 2012-2013. Dr. Desai was recruited to serve in our Leukemia Program to develop a clinical practice devoted to leukemia, myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN). She will be developing clinical and translational research protocols and projects in the areas of leukemia, MDS and MPN.Dr. Desai is published in Cancer Epidemiology Biomarkers Prevention and International Journal of Molecular Epidemiology and Genetics. She is the lead author and co-author on numerous WHI (Women's Health Initiative) paper proposals and has presented abstracts at national meetings. She is a member of American Society of Hematology (ASH) and American Society of Clinical Oncology (ASCO) and has served on the ASCO University Committee.

Biography: Fellowship: Hematology/Oncology at New York Presbyterian Hospital, 1997-2000Residency: New York Presbyterian Hospital, 1995-97Internship: The Beth Israel Hospital, Boston 1994-95Medical School: The Mount Sinai School of Medicine, New York, 1994Undergraduate: Yale University, 1990

Care Philosophy: Dr. Ritchie's research interests are in the treatment of older patients with anemia, cytopenias, myelodysplastic syndromes, myeloproliferative disorders and acute leukemia. She is interested in finding better therapies and supportive care strategies for older patients. Dr. Ritchie is the principal investigator on clincal trials investigating new diagnostic techniques, supportive care strategies and therapeutics aimed at the older patient. She collaborates with investigators in the Division of Geriatrics and Gerontology. She has been the author or co-author of many publications. She is interested in improving the medical care of older patients with hematologic malignancies.

Care Philosophy: Working closely together I provide my patients with an individualized treatment plan that best fits their disease and lifestyle Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with a physician office that they are still a participating provider.

Biography: Dr. Groisberg is a medical oncologist with a specialty in melanoma, sarcoma, and clinical trials. He is the author or co-author of numerous publications, reviews, book chapters, abstracts, and presentations related to targeted therapy in cancer, especially related to sarcomas